Geode Capital Management LLC Acquires 6,164 Shares of Encompass Health Co. (NYSE:EHC)

Geode Capital Management LLC grew its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 0.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,679,774 shares of the company's stock after acquiring an additional 6,164 shares during the period. Geode Capital Management LLC owned about 1.67% of Encompass Health worth $155,176,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Encompass Health by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company's stock valued at $960,817,000 after acquiring an additional 138,196 shares in the last quarter. State Street Corp boosted its stake in shares of Encompass Health by 0.7% during the 3rd quarter. State Street Corp now owns 3,025,769 shares of the company's stock valued at $292,410,000 after purchasing an additional 21,329 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of Encompass Health by 6.0% during the fourth quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company's stock valued at $191,799,000 after buying an additional 117,617 shares during the period. Copeland Capital Management LLC raised its stake in Encompass Health by 0.7% in the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company's stock worth $119,418,000 after buying an additional 8,548 shares in the last quarter. Finally, Norges Bank purchased a new stake in Encompass Health in the fourth quarter worth about $100,637,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.10% of the company's stock.

Encompass Health Stock Up 0.1 %

Shares of EHC traded up $0.08 on Friday, hitting $102.21. 971,045 shares of the stock traded hands, compared to its average volume of 660,681. Encompass Health Co. has a one year low of $78.53 and a one year high of $104.55. The company has a market capitalization of $10.29 billion, a PE ratio of 22.92, a P/E/G ratio of 2.31 and a beta of 0.87. The business has a 50 day simple moving average of $99.56 and a 200 day simple moving average of $98.02. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, equities analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's payout ratio is presently 15.25%.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Royal Bank of Canada reissued an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com lowered Encompass Health from a "buy" rating to a "hold" rating in a research report on Thursday, April 3rd. KeyCorp boosted their target price on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Monday, February 10th. William Blair reissued an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, Barclays upped their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Encompass Health currently has an average rating of "Buy" and a consensus target price of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.